At the core of drug development is scientific discovery. Translating discovery into a new standard of care happens in a successful clinical trial. Bringing new medications to market is a costly and painstaking process that presents many challenges along the way for drug developers. Clinical trials, especially in early phase, are a critical step on the path to approval. Today’s trials are providing more insights on rare disease research, antibodies, partnerships — and even setbacks.

This industry report examines how a partner can help manage some of the pressures in clinical trials and how studies can yield discoveries even when they fail. We'll explore:

• An agile CRO partner who can accelerate early phase success.
• Valuable datapoints from setbacks in certain approaches to treating Alzheimer’s.
• The transformative impact of antibody drug discovery on rare disease research.
• A Q&A with researchers optimizing chemotherapy or targeted therapy approaches in breast cancer treatment.

​